IL6 and chronic obstructive pulmonary disease: SuPAR which is also induced by IL-6, have more direct effect in formation of the atherosclerotic plaques [29, 30], and therefore, may be a more specific biomarker of endothelial dysfunction in COPD than other circulating mediators.